GLP-1 receptor agonists enhance insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite, all mechanisms that help control glucose while also promoting satiety and caloric reduction
Tirzepatide has a dual-hormone approach (GLP-1 and GIP), which may offer even greater weight loss
keep exercising and managing your diet
Retatrutide Dosing After 40: When to Increase, When to Hold, and When You're Getting It Wrong Rob Lagana Feb 24 5 min read Updated: Apr 12 The most common question we get from clients on Retatrutide is: "Should I increase my dose?" The answer is almost always the same: not yet
Some researchers have suggested this could paradoxically be protective long-term, as Cyp2e1 itself generates reactive oxygen species that contribute to liver damage
SOLSTICE Trial Results Sponsored by AstraZeneca, the SOLSTICE trial enrolled 406 adults with type 2 diabetes across nine countries, including the United States
